- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01422070
European Mortality & Length Of Intensive Care Unit (ICU) Stay Evaluation (ELOISE) (ELOISE)
A Multi-centre European Observational Study to Assess Whether Patients Admitted to the ICUs With Availability of Intermediate Care Unit (IMCU) Have Lower Hospital Mortality Than Those Admitted to the ICUs Without Availability of IMCU
The starting point of ELOISE is the significant number of Intensive Care Unit (ICU) survivors who die after the transfer to ward. This mortality rate nullifies the sophisticated diagnostics and the life-support therapies adopted in the ICU.
The inadequate care available at the destination ward has been suggested as one of the reasons to explain the bad outcome of some ICU survivors, but most hospitals do not have enough ICU beds to prolong the ICU stay until the patient has fully recovered. Therefore, Inter Mediate Care Units (IMCU) with levels of nursing staff and costs lower than ICU but higher than wards have been proposed to facilitate discharges of ICU patients. Unfortunately the literature does provide evidence of efficacy of IMCU.
The primary aim of the study is to assess whether the patients admitted to ICUs with availability of IMCU have lower hospital mortality than those admitted to the ICU without availability of IMCU.
Secondary aims are as follows:
- To compare Lengths Of ICU and Hospital Stay (LOIS and LOHS, respectively) of patients admitted to ICUs with or without availability of IMCU.
- To assess the influence of IMCU on the rate of ICU readmissions.
- To compare the hospital survival of patients discharged to IMCU and general ward (in hospital with or without availability of IMCU) adjusted for severity of illness and nursing workload at ICU discharge. This last aim will require a larger sample size (more than 10,000), but we hope to collect such a sample.
Study Overview
Status
Conditions
Detailed Description
Despite the high cost of Intensive Care Unit (ICU), a significant number of patients surviving intensive care die subsequently in hospital after the transfer to ward. Mortality rates after discharge from ICU have been reported to range from 6.1 to 27%
In 2000, it was reported that premature discharge from ICU was more likely to occur at night and was associated with higher death rates. Suggested factors that might account for a worse outcome for night discharges were poorer quantity and quality of care available at night both during transfer and at the destination. The implication of this study for the health system was that many hospitals did not have enough ICU beds. To facilitate earlier ICU discharges of ICU patients who are thought to need more care than those which can be provided on wards, InterMediate Care Units (IMCU) with level of nursing staff (and costs) lower than ICU were proposed more than a decade ago.
Despite the relevance of the topic, the literature on the efficacy and cost-effectiveness of IMCU available at present shows variable results. And the potential benefits of IMCUs remain uncertain.
The most striking are probably the following questions:
- Does IMCU decrease the hospital mortality rate of ICU patients?
- Does IMCU allow earlier ICU discharge and hence improve patients flux through the ICU and reduce ICU cost?
- Does IMCU permit a reduction of ICU readmissions? We propose to address these issues in a large multinational, multicentre study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ferrara, Italy, 44121
- Maurizia Capuzzo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- admission to one of the Study Unit
- any organ support allowed
- age of at least 16 years
Exclusion Criteria:
- age lower than 16 years
- patients admitted as donor for transplant
- patients admitted with limitation of care stated before admission
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients admitted to the Study Units
Consecutive adult patients consecutively admitted to the Study Units during one month (either from 7th November to 4th December 2010, or from 16th January to 12th February 2012)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vital Status at Hospital Discharge
Time Frame: Max 90 days after admission to the Study Unit
|
Hospital mortality of the patients admitted to intensive care units with or without intermediate care unit in the hospital
|
Max 90 days after admission to the Study Unit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of ICU Stay
Time Frame: Max 90 days after admission to intensive care unit
|
Number of days (calendar days -1) from admission to and discharge from the Study Unit
|
Max 90 days after admission to intensive care unit
|
Length of Hospital Stay
Time Frame: Max 90 days after admission to the Study Unit
|
Number of days (calendar days -1) from admission to the Study Unit to discharge from the hospital
|
Max 90 days after admission to the Study Unit
|
Number of ICU Readmissions
Time Frame: Max 90 days after admission to the Study Unit
|
Number of readmissions to intensive care unit during the same hospital course
|
Max 90 days after admission to the Study Unit
|
Collaborators and Investigators
Investigators
- Principal Investigator: Maurizia Capuzzo, MD, Azienda Ospedaliero-Universitaria di Ferrara, Italy
- Study Chair: Christophe Combescure, Statistician, University of Geneva, Switzerland
- Study Chair: Bertrand Guidet, PhD, Hôpital Saint-Antoine, Paris, France
- Study Chair: Gaetano Iapichino, MD, Hospital San Paolo, University of Milan, Italy
- Study Chair: Paolo Merlani, MD, University of Geneva, Switzerland
- Study Chair: Rui P Moreno, PhD, Hospital de Santo Antonio dos Capuchos, Lisbon, Portugal
- Study Chair: Thomas Perneger, Statistician, University of Geneva, Switzerland
- Study Chair: Andrew Rhodes, PhD, St George's Hospital, London, UK
- Study Chair: Andreas Valentin, MD, University of Vienna, Austria
Publications and helpful links
General Publications
- Capuzzo M, Volta C, Tassinati T, Moreno R, Valentin A, Guidet B, Iapichino G, Martin C, Perneger T, Combescure C, Poncet A, Rhodes A; Working Group on Health Economics of the European Society of Intensive Care Medicine. Hospital mortality of adults admitted to Intensive Care Units in hospitals with and without Intermediate Care Units: a multicentre European cohort study. Crit Care. 2014 Oct 9;18(5):551. doi: 10.1186/s13054-014-0551-8.
- Poncet A, Perneger TV, Merlani P, Capuzzo M, Combescure C. Determinants of the calibration of SAPS II and SAPS 3 mortality scores in intensive care: a European multicenter study. Crit Care. 2017 Apr 4;21(1):85. doi: 10.1186/s13054-017-1673-6.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 80-2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
University Hospital Birmingham NHS Foundation TrustCompletedRehabilitation After Critical Illness
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Insel Gruppe AG, University Hospital BernMonash UniversityNot yet recruitingMuscle Weakness | Critical Illness Myopathy | Physical Inactivity | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathySwitzerland